Tarsus Pharmaceuticals (TARS) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Tarsus Pharmaceuticals

· TARS

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

3.588 B

+2.50%

Tarsus Pharmaceuticals (TARS) Company Statistics | The Fly

General

Market Cap: $3.59B
Enterprise Value: $3.27B
Shares Outstanding: 43,020,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 90.59%
Operating Margin: -8.00%
Net Profit Margin: -7.67%
FCF Margin: 10.15%
ROA: -7.60%
ROE: -13.53%
ROIC: -11.15%
Current Ratio: 3.20
Debt-to-Equity: 0.26
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 5.58
P/FCF: 54.95
P/B: 9.75
EV/EBITDA: -92.75

Growth

Rev 1Y: 146.71%
Rev 1Y Fwd Est: 58.78%
Rev 3Y (CAGR): 159.54%
Rev 5Y (CAGR): —

Income Statement (TTM)

Revenue: $606.33M
Gross Margin: 90.59%
Operating Expenses: $597.84M
Operating Income: -$48.54M
Net Profit: -$46.48M

Balance Sheet

Rev 10Y (CAGR)

—

EPS 1Y

—

EPS 1Y Fwd Est

—

EPS 3Y (CAGR)

—

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $204.6M
Working Capital: $386.24M
Total Assets: $611.14M
Net Debt: -$115.94M
Total Liabilities: $264.41M
Total Equity: $346.73M

Cash Flow Statement (TTM)

Cash Flow from Operations: $79.7M
Cash Flow from Investing: $23.85M
Cash Flow from Financing: $9.61M
Free Cash Flow: $61.55M
Capital Expenditures: $18.16M